211 related articles for article (PubMed ID: 35592529)
1. Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity.
Tu Z; Li J; Long X; Wu L; Zhu X; Huang K
Oxid Med Cell Longev; 2022; 2022():9408886. PubMed ID: 35592529
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas.
Tu Z; Ji Q; Han Q; Long X; Li J; Wu L; Huang K; Zhu X
BMC Cancer; 2022 Sep; 22(1):973. PubMed ID: 36096781
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
Hu Y; Tu Z; Lei K; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma.
Liu DL; Wu MY; Zhang TN; Wang CG
Front Mol Biosci; 2022; 9():807502. PubMed ID: 35155577
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma.
Yan X; Ji H; Liu Z; Ma S; Dong J; Jiang X; Hu X; Wang F; Zhao H; Jin J; Zhang J; Wang N; Du J; Hu S
Front Genet; 2022; 13():880864. PubMed ID: 35559020
[No Abstract] [Full Text] [Related]
6. Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy.
Song B; Peng Y; Zheng Y; Zhu Y; Liu W; Wang K; Cui Z; Song B
Cancer Immunol Immunother; 2023 Nov; 72(11):3523-3541. PubMed ID: 37638981
[TBL] [Abstract][Full Text] [Related]
7. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
8. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
[No Abstract] [Full Text] [Related]
9. Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2.
Liu Y; Chou FJ; Lang F; Zhang M; Song H; Zhang W; Davis DL; Briceno NJ; Zhang Y; Cimino PJ; Zaghloul KA; Gilbert MR; Armstrong TS; Yang C
Clin Cancer Res; 2023 Apr; 29(7):1305-1316. PubMed ID: 36648507
[TBL] [Abstract][Full Text] [Related]
10. Characterization of aging tumor microenvironment with drawing implications in predicting the prognosis and immunotherapy response in low-grade gliomas.
Zhou Z; Wei J; Jiang W
Sci Rep; 2022 Mar; 12(1):5457. PubMed ID: 35361903
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma.
Zhang G; Chen A; Fang J; Wu A; Chen G; Tai P; Chen H; Chen X; Cao K
Front Immunol; 2023; 14():1105210. PubMed ID: 37114037
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the Role of Pyroptosis in Lower-Grade Glioma: Development of a Novel Scoring System to Enhance Personalized Therapeutic Approaches.
Chen X; Xu Y; Wang M; Ren C
J Mol Neurosci; 2023 Aug; 73(7-8):649-663. PubMed ID: 37566191
[TBL] [Abstract][Full Text] [Related]
13. Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
Zhang L; Qu C; Shi C; Wu F; Tang Y; Li Y; Li J; Feng H; Zhong S; Yang J; Zeng X; Peng X
PLoS One; 2023; 18(1):e0279119. PubMed ID: 36649311
[TBL] [Abstract][Full Text] [Related]
14. TFR2 regulates ferroptosis and enhances temozolomide chemo-sensitization in gliomas.
Tong S; Hong Y; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Chen Q; Tian D
Exp Cell Res; 2023 Mar; 424(1):113474. PubMed ID: 36702193
[TBL] [Abstract][Full Text] [Related]
15. m
Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Wei Y; Duan S; Gong F; Li Q
Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
Xia QD; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Liu Z; Hu J; Wang SG
Front Cell Dev Biol; 2022; 10():832892. PubMed ID: 35386202
[No Abstract] [Full Text] [Related]
18. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
[TBL] [Abstract][Full Text] [Related]
19. Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients.
Wang P; Li J; Wu M; Ye M; Huang K; Zhu X
Front Immunol; 2021; 12():722479. PubMed ID: 34566979
[TBL] [Abstract][Full Text] [Related]
20. Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development.
Zhao Z; Xing N; Guo H; Li J; Sun G
Pharmgenomics Pers Med; 2024; 17():105-123. PubMed ID: 38623558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
